Involvement of Angiotensin II Type 1 Receptor and Calcium Channel in Vascular Remodeling and Endothelial Dysfunction in Rats with Pressure Overload

Abstract

Vascular remodeling is an adaptive response to various stimuli, including mechanical forces, inflammatory cytokines and hormones. In the present study, we investigated the role of angiotensin II type 1 receptor (AT1R) and calcium channel in carotid artery remodeling in response to increased biomechanical forces by using the transverse aortic constriction (TAC) rat model. TAC was induced on ten-week-old male Sprague-Dawley rats and these models were treated with AT1R blocker olmesartan (1 mg/kg/day) or/and calcium channel blocker (CCB) amlodipine (0.5 mg/kg/day) for 14 days. After the treatment, the right common carotid artery proximal to the band (RCCA-B) was collected for further assay. Results showed that olmesartan, but not amlodipine, significantly prevented TAC-induced adventitial hyperplasia. Similarly, olmesartan, but not amlodipine, signifcantly prevented vascular infammation, as indicated by increased tumor necrosis factor α (TNF-α) and increased p65 phosphorylation, an indicator of nuclear factor κ-light-chain-enhancer of activated B cells (NFκB) activation in RCCA-B. In contrast, both olmesartan and amlodipine reversed the decreased expression of endothelial nitric oxidase synthase (eNOS) and improved endothelium-dependent vasodilation, whereas combination of olmesartan and amlodipine showed no further synergistic protective effects. These results suggest that AT1R was involved in vascular remodeling and inflammation in response to pressure overload, whereas AT1R and subsequent calcium channel were involved in endothelial dysfunction.

Keywords

transverse aortic constriction / angiotensin II type 1 receptor / calcium channel / vascular remodeling / endothelial dysfunction

References

[1] KuangSQ, GengL, PrakashSK, et al.. Aortic remodeling after transverse aortic constriction in mice is attenuated with AT1 receptor blockade. Arterioscler Thromb Vasc Biol, 2013, 33(9): 2172-2179

[2] ChenJ, WuJ, LiL, et al.. Effect of an acute mechanical stimulus on aortic structure in the transverse aortic constriction mouse model. Clin Exp Pharmacol Physiol, 2011, 38(9): 570-576

[3] KwonJS, LeeSJ, KimYG, et al.. Effect of pressure overload and its recovery on the rat carotid artery: change of vascular reactivity and remodeling process. Heart Vessels, 2006, 21(1): 48-55

[4] WangK, LuD, ZhangB, et al.. Renal Denervation Attenuates Multi-Organ Fibrosis and Improves Vascular Remodeling in Rats with Transverse Aortic Constriction Induced Cardiomyopathy. Cell Physiol Biochem, 2016, 40(3–4): 465-476

[5] LiY, JiangH, RuanC, et al.. The interaction of transient receptor potential melastatin 7 with macrophages promotes vascular adventitial remodeling in transverse aortic constriction rats. Hypertens Res, 2014, 37(1): 35-42

[6] MaiellaroK, TaylorWR. The role of the adventitia in vascular inflammation. Cardiovasc Res, 2007, 75(4): 640-648

[7] AndersenJK, OmaI, PraysonRA, et al.. Inflammatory cell infiltrates in the heart of patients with coronary artery disease with and without inflammatory rheumatic disease: a biopsy study. Arthritis Res Ther, 2016, 18(1): 232

[8] MollerK, PoselC, KranzA, et al.. Arterial Hypertension Aggravates Innate Immune Responses after Experimental Stroke. Front Cell Neurosci, 2015, 9: 461

[9] Rodriguez-CarrioJ, LopezP, SuarezA. Endothelial Progenitor Cells as Mediators of the Crosstalk between Vascular Repair and Immunity: Lessons from Systemic Autoimmune Diseases. Curr Med Chem, 2018, 25(35): 4478-4496

[10] TellidesG, PoberJS. Inflammatory and immune responses in the arterial media. Circ Res, 2015, 116(2): 312-322

[11] ZhangBN, ZhangX, XuH, et al.. Dynamic Variation of RAS on Silicotic Fibrosis Pathogenesis in Rats. Curr Med Sci, 2019, 39(4): 551-559

[12] GhaziL, DrawzP. Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathy. F1000Res, 20176

[13] LiFF, ShangXK, DuXL, et al.. Rapamycin Treatment Attenuates Angiotensin II -induced Abdominal Aortic Aneurysm Formation via VSMC Phenotypic Modulation and Down-regulation of ERK1/2 Activity. Curr Med Sci, 2018, 38(1): 93-100

[14] XuR, ZhangZZ, ChenLJ, et al.. Ascending aortic adventitial remodeling and fibrosis are ameliorated with Apelin-13 in rats after TAC via suppression of the miRNA-122 and LGR4-beta-catenin signaling. Peptides, 2016, 86: 85-94

[15] OgawaH, Kim-MitsuyamaS, JinnouchiT, et al.. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160). Hypertens Res, 2009, 32(7): 575-580

[16] AkhrassPR, McFarlaneSI. Telmisartan and cardioprotection. Vasc Health Risk Manag, 2011, 7: 677-683

[17] KoniariK, ParissisJ, ParaskevaidisI, et al.. Treating volume overload in acutely decompensated heart failure: established and novel therapeutic approaches. Eur Heart J Acute Cardiovasc Care, 2012, 1(3): 256-268

[18] YeY, GongH, WangX, et al.. Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload-induced Cardiac Hypertrophy and Remodeling in Male Mice. J Cardiovasc Pharmacol, 2015, 65(6): 628-639

[19] GeCJ, LuSZ, ChenYD, et al.. Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia. Heart Vessels, 2008, 23(2): 91-95

[20] IkedaH, MinamikawaJ, NakamuraY, et al.. Comparison of effects of amlodipine and angiotensin receptor blockers on the intima-media thickness of carotid arterial wall (AAA study: amlodipine vs. ARB in atherosclerosis study). Diabetes Res Clin Pract, 2009, 83(1): 50-53

[21] StantonAV, ChapmanJN, MayetJ, et al.. Effects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common carotid artery. Clin Sci (Lond), 2001, 101(5): 455-464

[22] MontezanoAC, NguyenD C A, RiosFJ, et al.. Angiotensin II and vascular injury. Curr Hypertens Rep, 2014, 16(6): 431

[23] LiFF, ShangXK, DuXL, et al.. Rapamycin Treatment Attenuates Angiotensin II -induced Abdominal Aortic Aneurysm Formation via VSMC Phenotypic Modulation and Down-regulation of ERK1/2 Activity. Curr Med Sci, 2018, 38(1): 93-100

[24] NguyenD C A, TouyzRM. A new look at the renin-angiotensin system-focusing on the vascular system. Peptides, 2011, 32(10): 2141-2150

[25] InabaS, IwaiM, TomonoY, et al.. Prevention of vascular injury by combination of an AT1 receptor blocker, olmesartan, with various calcium antagonists. Am J Hypertens, 2009, 22(2): 145-150

[26] StepienO, MarcheP. Amlodipine inhibits thapsigargin-sensitive CA(2+) stores in thrombin-stimulated vascular smooth muscle cells. Am J Physiol Heart Circ Physiol, 2000, 279(3): H1220-1227

[27] WhittakerP, ZhangHP, KlonerRA. Biphasic survival response to amlodipine after myocardial infarction in rats: Association with cardiac vascular remodeling. Cardiovasc Pathol, 2000, 9(2): 85-93

[28] ZamaniP, GanzP, LibbyP, et al.. Relationship of antihypertensive treatment to plasma markers of vascular inflammation and remodeling in the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis study. Am Heart J, 2012, 163(4): 735-740

[29] ZhouMS, JaimesEA, RaijL. Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats. Am J Hypertens, 2004, 17(2): 167-171

[30] OyamaJ, NodeK. Endothelium-derived hyperpolarizing factor and hypertension. Hypertens Res, 2013, 36(10): 852-853

[31] MatlibMA. Relaxation of potassium chloride-induced contractions by amlodipine and its interaction with the 1, 4-dihydropyridine-binding site in pig coronary artery. Am J Cardiol, 1989, 64(17): 51